Also trades as: BIO-B (NYSE) · $vol 0M
BIO NYSE
Bio-Rad Laboratories, Inc.
1W: +7.4%
1M: +0.8%
3M: +16.4%
YTD: +24.8%
1Y: +12.1%
3Y: +22.5%
5Y: -48.0%
$380.99
+8.56 (+2.30%)
Weekly Expected Move ±4.9%
$334
$352
$370
$388
$406
Credit Risk of going bust: lower than 70% of companies Debt: 10.6% of company value Bonds: $41.6M held by 57 funds, 79 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $4.63 (down 99%), Bio-Rad Laboratories, Inc. would be worth roughly what it owes.
Total debt $1.20B against a stock market value of $10.19B.
Distance to default 7.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $802.2M (short-term plus half of long-term), stock volatility 36.7%; Altman Z 3.86. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $4.63 (down 99%), Bio-Rad Laboratories, Inc. would be worth roughly what it owes.
Total debt $1.20B against a stock market value of $10.19B.
Distance to default 7.62 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $802.2M (short-term plus half of long-term), stock volatility 36.7%; Altman Z 3.86. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (60)
Adial Pharmaceuticals to appoint Celia Economides as CFO
Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now
California State Teachers Retirement System Has $1.79 Billion Position in Bio-Rad Laboratories, Inc. $BIO
Public Employees Retirement System of Ohio Makes New $1.61 Million Investment in Bio-Rad Laboratories, Inc. $BIO
Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?
Bio-Rad (BIO) Up 11.7% Since Last Earnings Report: Can It Continue?
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
First Trust Advisors LP Has $424,000 Position in Bio-Rad Laboratories, Inc. $BIO
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock
Assenagon Asset Management S.A. Acquires 85,393 Shares of Bio-Rad Laboratories, Inc. $BIO
Amundi Has $10.81 Million Holdings in Bio-Rad Laboratories, Inc. $BIO
Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates
Assetmark Inc. Raises Stock Holdings in Bio-Rad Laboratories, Inc. $BIO
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories
Nasdaq 100 Drops Over 1%, Oil Tops $106 On Iran Impasse: Stock Market Today
Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript
Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU
Bio-Rad (BIO) Q1 2026 Earnings Transcript
Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption
Bio-Rad Laboratories (BIO) Lags Q1 Earnings Estimates
Transcript: Bio-Rad Laboratories Q1 2026 Earnings Conference Call
Here are the major earnings after the close Thursday
Earnings Scheduled For April 30, 2026
Boston Trust Walden Corp Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO
Longleaf Partners Global Fund exits BIO, DIS among Q1 moves
Bio-Rad Laboratories, Inc. $BIO Shares Bought by Assetmark Inc.
Allspring Global Investments Holdings LLC Decreases Stake in Bio-Rad Laboratories, Inc. $BIO
Exchange Traded Concepts LLC Has $8.97 Million Stock Holdings in Bio-Rad Laboratories, Inc. $BIO
Why Is Agilent (A) Down 6.2% Since Last Earnings Report?
Dynamic Technology Lab Private Ltd Takes $926,000 Position in Bio-Rad Laboratories, Inc. $BIO
Dimensional Fund Advisors LP Purchases 63,370 Shares of Bio-Rad Laboratories, Inc. $BIO
Fisher Asset Management LLC Lowers Stock Position in Bio-Rad Laboratories, Inc. $BIO
FibroBiologics to Present at the BIO Investment & Growth Summit
International Markets and Bio-Rad (BIO): A Deep Dive for Investors
Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results
Allianz Asset Management GmbH Boosts Position in Bio-Rad Laboratories, Inc. $BIO
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
BIO-key EMEA Subsidiary Partners with Citadel Global to Expand India Presence and Accelerate Adoption of Biometric Identity Solutions in Support of EU–India Free Trade Agreement
BIO-key and Visualforma Awarded Contract to Secure Digital Identities for Large Municipality in Portugal
Campbell & CO Investment Adviser LLC Makes New Investment in Bio-Rad Laboratories, Inc. $BIO
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now
Biometric Identification and Cybersecurity Software Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference at 11:30am ET, Jan. 28 in Atlantic City, NJ
Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of “Hold” from Brokerages
Exchange Traded Concepts LLC Buys 7,648 Shares of Bio-Rad Laboratories, Inc. $BIO
Texas Permanent School Fund Corp Lowers Position in Bio-Rad Laboratories, Inc. $BIO
Federated Hermes Inc. Has $30.66 Million Position in Bio-Rad Laboratories, Inc. $BIO
Ariel Investments LLC Has $197.55 Million Stock Holdings in Bio-Rad Laboratories, Inc. $BIO
Fisher Asset Management LLC Sells 5,884 Shares of Bio-Rad Laboratories, Inc. $BIO
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
Artisan Partners Limited Partnership Sells 1,670 Shares of Bio-Rad Laboratories, Inc. $BIO